Bioengineered nanovesicles could improve cancer treatment

Nanovesicles can be bioengineered to target cancer cells and deliver treatments directly, according to research at Binghamton University, State University of New York.

GLP-1 therapy boosts visceral fat metabolism, driving weight loss

Researchers discuss the role of enhanced visceral adipose tissue metabolism in mediating weight loss by glucagon-like peptide-1 drugs.

August 26, 2024

Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024 – Biotech Investments

EQS-News: Heidelberg Pharma AG / Key word(s): Conference Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024 24.10.2024 / 11:03 CET/CEST

October 25, 2024

Study sheds light on the susceptibility of Chinese men to 60 diseases related to alcohol consumption

Recently, a study conducted by researchers from Peking University and Oxford Population Health shed light on the susceptibility of Chinese men to 60 diseases related

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.